Payment overview · 2025
General Payments
1 reported records · 1 companies
Healthcare provider profile · identity verified
Allopathic & Osteopathic Physicians|General Practice · SAN JUAN, PR · NPI 1326209073
Verified facts
CMS Open Payments records show Luis Marrero Abascal, MD received $26.41 in general payments during 2025 across 1 reported records.
Corcept Therapeutics accounted for 100.0% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 1 associated product.
These records do not establish that a payment influenced prescribing or medical care.
Payment overview · 2025
1 reported records · 1 companies
Separate record types
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| Corcept Therapeutics | Unresolved — no canonical attribution shown | $26.41 | 100.0% | 1 | 2025 |
What were the payments for?
| Category | Amount | Records |
|---|---|---|
| Food and Beverage | $26.41 | 1 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| Korlym Normalized: korlym |
Drug | Corcept Therapeutics | $26.41 | 1 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
No exact normalized or approved-alias overlap was found in the loaded Part D year. This does not mean the doctor never prescribed the product.
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
No publishable same-company prescribing overlap was found in the loaded Part D year. This does not mean the doctor never prescribed a drug reported elsewhere by a paying company.
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Rosuvastatin Calcium | Rosuvastatin Calcium | 884 | 292 |
| Atorvastatin Calcium | Atorvastatin Calcium | 600 | 199 |
| Amlodipine Besylate | Amlodipine Besylate | 429 | 145 |
| Ezetimibe | Ezetimibe | 429 | 138 |
| Lisinopril | Lisinopril | 388 | 123 |
| Losartan Potassium | Losartan Potassium | 372 | 114 |
| Gabapentin | Gabapentin | 360 | 135 |
| Levothyroxine Sodium | Levothyroxine Sodium | 359 | 114 |
| Omeprazole | Omeprazole | 348 | 108 |
| Ibuprofen | Ibuprofen | 319 | 132 |
| Metformin Hcl | Metformin Hcl | 300 | 113 |
| Pantoprazole Sodium | Pantoprazole Sodium | 272 | 102 |
| Temazepam | Temazepam | 260 | 39 |
| Tamsulosin Hcl | Tamsulosin Hcl | 250 | 99 |
| Fenofibrate | Fenofibrate | 241 | 77 |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 235 | 170 |
| Metoprolol Tartrate | Metoprolol Tartrate | 226 | 70 |
| Furosemide | Furosemide | 217 | 74 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 201 | 67 |
| Alprazolam | Alprazolam | 192 | 35 |
| Clonazepam | Clonazepam | 191 | 51 |
| Pioglitazone Hcl | Pioglitazone Hcl | 183 | 58 |
| Sulfamethoxazole-Trimethoprim | Sulfamethoxazole/Trimethoprim | 178 | 126 |
| Tizanidine Hcl | Tizanidine Hcl | 172 | 80 |
| Metoprolol Succinate | Metoprolol Succinate | 164 | 56 |
| Glipizide-Metformin | Glipizide/Metformin Hcl | 157 | 52 |
| Meloxicam | Meloxicam | 155 | 42 |
| Tramadol Hcl | Tramadol Hcl | 154 | 51 |
| Losartan-Hydrochlorothiazide | Losartan/Hydrochlorothiazide | 150 | 48 |
| Clopidogrel | Clopidogrel Bisulfate | 145 | 50 |
| Montelukast Sodium | Montelukast Sodium | 144 | 56 |
| Hydrochlorothiazide | Hydrochlorothiazide | 132 | 43 |
| Zolpidem Tartrate | Zolpidem Tartrate | 132 | 18 |
| Eliquis | Apixaban | 127 | 40 |
| Metformin Hcl Er | Metformin Hcl | 124 | 54 |
| Azithromycin | Azithromycin | 121 | 101 |
| Alendronate Sodium | Alendronate Sodium | 115 | 32 |
| Trazodone Hcl | Trazodone Hcl | 114 | 41 |
| Famotidine | Famotidine | 112 | 43 |
| Pregabalin | Pregabalin | 109 | 26 |
| Carvedilol | Carvedilol | 106 | 40 |
| Pravastatin Sodium | Pravastatin Sodium | 102 | 35 |
| Hydroxyzine Pamoate | Hydroxyzine Pamoate | 98 | 45 |
| Sertraline Hcl | Sertraline Hcl | 95 | 37 |
| Baclofen | Baclofen | 94 | 18 |
| Levofloxacin | Levofloxacin | 93 | 74 |
| Methylprednisolone | Methylprednisolone | 93 | 70 |
| Potassium Chloride | Potassium Chloride | 88 | 24 |
| Fluticasone Propionate | Fluticasone Propionate | 85 | 36 |
| Invokana | Canagliflozin | 85 | 26 |
| Lorazepam | Lorazepam | 79 | 15 |
| Labetalol Hcl | Labetalol Hcl | 78 | 23 |
| Diclofenac Sodium | Diclofenac Sodium | 76 | 26 |
| Meclizine Hcl | Meclizine Hcl | 76 | 41 |
| Testosterone Cypionate | Testosterone Cypionate | 75 | 11 |
| Allopurinol | Allopurinol | 74 | 26 |
| Ondansetron Odt | Ondansetron | 70 | 45 |
| Simvastatin | Simvastatin | 70 | 24 |
| Xarelto | Rivaroxaban | 68 | 16 |
| Finasteride | Finasteride | 66 | 27 |
| Fluconazole | Fluconazole | 65 | 44 |
| Sildenafil Citrate | Sildenafil Citrate | 65 | 22 |
| Citalopram Hbr | Citalopram Hydrobromide | 63 | 23 |
| Ofloxacin | Ofloxacin | 60 | 50 |
| Escitalopram Oxalate | Escitalopram Oxalate | 59 | 22 |
| Trelegy Ellipta | Fluticasone/Umeclidin/Vilanter | 58 | 18 |
| Spironolactone | Spironolactone | 57 | 18 |
| Atenolol | Atenolol | 56 | 21 |
| Donepezil Hcl | Donepezil Hcl | 56 | 17 |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 52 | 21 |
| Ciprofloxacin Hcl | Ciprofloxacin Hcl | 51 | 45 |
| Duloxetine Hcl | Duloxetine Hcl | 48 | 14 |
| Jardiance | Empagliflozin | 47 | 19 |
| Propranolol Hcl | Propranolol Hcl | 46 | 15 |
| Lisinopril-Hydrochlorothiazide | Lisinopril/Hydrochlorothiazide | 44 | 14 |
| Diazepam | Diazepam | 43 | suppressed |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 41 | 22 |
| Glimepiride | Glimepiride | 41 | 14 |
| Levetiracetam | Levetiracetam | 41 | 15 |
| Enalapril Maleate | Enalapril Maleate | 40 | 16 |
| Tresiba Flextouch U-100 | Insulin Degludec | 39 | 13 |
| Naproxen | Naproxen | 38 | 18 |
| Hydralazine Hcl | Hydralazine Hcl | 37 | 13 |
| Diltiazem 24hr Er (Cd) | Diltiazem Hcl | 36 | 12 |
| Nifedipine Er | Nifedipine | 36 | 11 |
| Buspirone Hcl | Buspirone Hcl | 35 | 11 |
| Clonidine Hcl | Clonidine Hcl | 35 | 12 |
| Fluoxetine Hcl | Fluoxetine Hcl | 34 | 13 |
| Nitrofurantoin Mono-Macro | Nitrofurantoin Monohyd/M-Cryst | 34 | 16 |
| Amitriptyline Hcl | Amitriptyline Hcl | 33 | 13 |
| Ipratropium Bromide | Ipratropium Bromide | 32 | 11 |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 32 | 24 |
| Glipizide | Glipizide | 31 | 11 |
| Novolog Flexpen | Insulin Aspart | 31 | suppressed |
| Terazosin Hcl | Terazosin Hcl | 31 | suppressed |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 30 | 11 |
| Doxycycline Hyclate | Doxycycline Hyclate | 29 | 21 |
| Sucralfate | Sucralfate | 29 | 12 |
| Lantus | Insulin Glargine,hum.Rec.Anlog | 28 | 11 |
| Triamterene-Hydrochlorothiazid | Triamterene/Hydrochlorothiazid | 28 | suppressed |
| Myrbetriq | Mirabegron | 27 | 12 |
| Ondansetron Hcl | Ondansetron Hcl | 27 | suppressed |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 26 | 11 |
| Memantine Hcl | Memantine Hcl | 26 | suppressed |
| Oxybutynin Chloride | Oxybutynin Chloride | 26 | suppressed |
| Hydroxyzine Hcl | Hydroxyzine Hcl | 25 | 13 |
| Digoxin | Digoxin | 24 | suppressed |
| Paroxetine Hcl | Paroxetine Hcl | 24 | suppressed |
| Valsartan | Valsartan | 24 | suppressed |
| Loperamide | Loperamide Hcl | 23 | 14 |
| Mirtazapine | Mirtazapine | 23 | suppressed |
| Quetiapine Fumarate | Quetiapine Fumarate | 23 | suppressed |
| Diltiazem 24hr Er | Diltiazem Hcl | 22 | suppressed |
| Doxazosin Mesylate | Doxazosin Mesylate | 22 | suppressed |
| Esomeprazole Magnesium | Esomeprazole Magnesium | 22 | suppressed |
| Ozempic | Semaglutide | 22 | suppressed |
| Butalbital-Acetaminophen-Caffe | Butalb/Acetaminophen/Caffeine | 21 | suppressed |
| Lidocaine | Lidocaine | 21 | suppressed |
| Symbicort | Budesonide/Formoterol Fumarate | 21 | suppressed |
| Synthroid | Levothyroxine Sodium | 21 | suppressed |
| Topiramate | Topiramate | 21 | suppressed |
| Benazepril Hcl | Benazepril Hcl | 20 | suppressed |
| Hydrocodone-Acetaminophen | Hydrocodone/Acetaminophen | 20 | 13 |
| Latanoprost | Latanoprost | 20 | suppressed |
| Linzess | Linaclotide | 20 | suppressed |
| Nano 2nd Gen Pen Needle | Pen Needle, Diabetic | 20 | suppressed |
| Diltiazem Hcl | Diltiazem Hcl | 19 | suppressed |
| Estradiol | Estradiol | 19 | suppressed |
| Lamotrigine | Lamotrigine | 19 | suppressed |
| Bupropion Hcl Sr | Bupropion Hcl | 18 | suppressed |
| Bupropion Xl | Bupropion Hcl | 18 | suppressed |
| Dicyclomine Hcl | Dicyclomine Hcl | 18 | 12 |
| Entresto | Sacubitril/Valsartan | 18 | suppressed |
| Prednisone | Prednisone | 18 | 14 |
| Janumet | Sitagliptin Phos/Metformin Hcl | 17 | suppressed |
| Megestrol Acetate | Megestrol Acetate | 17 | suppressed |
| Amiodarone Hcl | Amiodarone Hcl | 16 | suppressed |
| Chlorthalidone | Chlorthalidone | 16 | suppressed |
| Farxiga | Dapagliflozin Propanediol | 16 | suppressed |
| Fluticasone-Salmeterol | Fluticasone Propion/Salmeterol | 16 | suppressed |
| Ropinirole Hcl | Ropinirole Hcl | 16 | suppressed |
| Tolterodine Tartrate Er | Tolterodine Tartrate | 16 | suppressed |
| Tresiba | Insulin Degludec | 16 | suppressed |
| Atrovent Hfa | Ipratropium Bromide | 15 | suppressed |
| Januvia | Sitagliptin Phosphate | 15 | suppressed |
| Lovastatin | Lovastatin | 15 | suppressed |
| Metronidazole | Metronidazole | 15 | 13 |
| Nystatin | Nystatin | 15 | suppressed |
| Cilostazol | Cilostazol | 14 | suppressed |
| Clorazepate Dipotassium | Clorazepate Dipotassium | 14 | suppressed |
| Methocarbamol | Methocarbamol | 14 | suppressed |
| Novolog | Insulin Aspart | 14 | suppressed |
| Acarbose | Acarbose | 13 | suppressed |
| Clotrimazole | Clotrimazole | 13 | suppressed |
| Nitroglycerin | Nitroglycerin | 13 | suppressed |
| Acyclovir | Acyclovir | 12 | suppressed |
| Celecoxib | Celecoxib | 12 | suppressed |
| Cephalexin | Cephalexin | 12 | suppressed |
| Ibu | Ibuprofen | 12 | suppressed |
| Janumet Xr | Sitagliptin Phos/Metformin Hcl | 12 | suppressed |
| Ketoconazole | Ketoconazole | 12 | suppressed |
| Olmesartan-Hydrochlorothiazide | Olmesartan/Hydrochlorothiazide | 12 | suppressed |
| Pramipexole Dihydrochloride | Pramipexole Di-Hcl | 12 | suppressed |
| Warfarin Sodium | Warfarin Sodium | 12 | suppressed |
| Dropsafe Prep Pads | Alcohol Antiseptic Pads | 11 | suppressed |
| Lansoprazole | Lansoprazole | 11 | suppressed |
| Methimazole | Methimazole | 11 | suppressed |
| Stiolto Respimat | Tiotropium Br/Olodaterol Hcl | 11 | suppressed |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 11 | suppressed |
Timeline
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $26.41 · 1 records | Corcept Therapeutics | Korlym | — | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error